Home › Cervical Cancer › Arizona › Phoenix
Cervical Cancer clinical trials in Phoenix, AZ
4 studies for Cervical Cancer are looking for participants at sites in and around Phoenix (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
RecruitingPhase 4
- HonorHealth Cancer Care - Biltmore - AZCCC Imaging, Phoenix
- HonorHealth Cancer Care - Biltmore - HonorHealth Research Pharmacy, Phoenix
- HonorHealth Research Institute (Arizona Center for Cancer Care) - HonorHealth Cancer Care -Biltmore, Phoenix
- and 2 more
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
RecruitingObservational study
- Mayo Clinic, Phoenix
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RecruitingPhase 1/2
- USOR HonorHealth, Phoenix
Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
RecruitingObservational study
- Mayo Clinic in Arizona, Phoenix
About Cervical Cancer
Cervical cancer starts in the cells of the cervix, which is the lower, narrow end of the uterus. Long-lasting HPV infection causes almost all cervical cancers.
More about Cervical Cancer on MedlinePlus
Cervical Cancer trials in other cities
- Houston, TX34 studies
- New York City, NY20 studies
- Nashville, TN19 studies
- Boston, MA19 studies
- Arlington, VA18 studies
- Los Angeles, CA17 studies
- San Antonio, TX14 studies
- Dallas, TX14 studies
- St. Louis, MO12 studies
- Orlando, FL12 studies
- Columbus, OH12 studies
- Baldwin Park, CA11 studies
Other studies in Phoenix
- Breast Cancer25 studies
- Colorectal Cancer24 studies
- Non-Small Cell Lung Cancer21 studies
- Metastatic Cancer19 studies
- Obesity19 studies
- Pancreatic Cancer18 studies
- Cancer (all types)17 studies
- Cardiovascular Disease16 studies
- Prostate Cancer16 studies
- Multiple Myeloma16 studies
- Heart Failure16 studies
- Alzheimer's Disease15 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.